{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:16:21Z","timestamp":1792700181733,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018571","name":"Specific Research Project of Guangxi for Research Bases and Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116806","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:10:45Z","timestamp":1725088245000},"page":"116806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design and synthesis of Thieno[3, 2-b]pyridinone derivatives exhibiting potent activities against Mycobacterium tuberculosis in vivo by targeting Enoyl-ACP reductase"],"prefix":"10.1016","volume":"279","author":[{"given":"Lihong","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1763-4398","authenticated-orcid":false,"given":"Niuniu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116806_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114066","article-title":"Tuberculosis drug discovery: progression and future interventions in the wake of emerging resistance","volume":"229","author":"Perveen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib2","doi-asserted-by":"crossref","first-page":"16597","DOI":"10.1021\/acs.jmedchem.3c01054","article-title":"Discovery and mechanistic study of novel Mycobacterium tuberculosis ClpP1P2 inhibitors","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib3","series-title":"Global Tuberculosis Report 2023","year":"2023"},{"key":"10.1016\/j.ejmech.2024.116806_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115617","article-title":"Antimycobacterial pyridine carboxamides: from design to in vivo activity","volume":"258","author":"Nawrot","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115611","article-title":"2, 6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1","volume":"258","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/acs.jmedchem.0c01727","article-title":"Antitubercular 2-pyrazolylpyrimidinones: structure-activity relationship and mode-of-action studies","volume":"64","author":"Soares de Melo","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib7","doi-asserted-by":"crossref","first-page":"14724","DOI":"10.1021\/acs.jmedchem.3c01273","article-title":"Dual inhibition of Mycobacterium tuberculosis and the host TGFBR1 by an anilinoquinazoline","volume":"66","author":"Nandakumar","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115351","article-title":"Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents","volume":"255","author":"Wen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114916","article-title":"Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization","volume":"245","author":"Girardini","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib10","doi-asserted-by":"crossref","first-page":"15073","DOI":"10.1021\/acs.jmedchem.3c01172","article-title":"Unnatural endotype B PPAPs as novel compounds with activity against Mycobacterium tuberculosis","volume":"66","author":"Peslalz","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tube.2017.12.006","article-title":"Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis","volume":"108","author":"Fujiwara","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2024.116806_bib12","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/cid\/ciaa1064","article-title":"Multidrug resistant tuberculosis with simultaneously acquired drug resistance to bedaquiline and delamanid","volume":"73","author":"Yoshiyama","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116806_bib13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/cid\/ciz074","article-title":"Emergence of low-level delamanid and bedaquiline resistance during extremely drug-resistant tuberculosis treatment","volume":"69","author":"Polsfuss","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116806_bib14","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/jac\/dkaa136","article-title":"Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid","volume":"75","author":"Kadura","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2024.116806_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114946","article-title":"Pyrimidine derivatives with antitubercular activity","volume":"246","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib16","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1021\/acs.jmedchem.6b01277","article-title":"Discovery of Mycobacterium tuberculosis InhA inhibitors by binding sites comparison and ligands prediction","volume":"59","author":"\u0160tular","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2174\/156802612799984535","article-title":"Targeting InhA, the FASII enoyl-ACP reductase: SAR studies on novel inhibitor scaffolds","volume":"12","author":"Pan","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib18","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.00112-06","article-title":"Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis","volume":"50","author":"Hazb\u00f3n","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116806_bib19","doi-asserted-by":"crossref","first-page":"11056","DOI":"10.1021\/acs.jmedchem.3c00358","article-title":"Design, synthesis, and evaluation of novel \u03b42-thiazolino 2-pyridone derivatives that potentiate isoniazid activity in an isoniazid-resistant Mycobacterium tuberculosis mutant","volume":"66","author":"Sarkar","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib20","doi-asserted-by":"crossref","first-page":"1041.e1","DOI":"10.1016\/j.cmi.2018.12.008","article-title":"Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates","volume":"8","author":"Islam","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2024.116806_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115646","article-title":"Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA","volume":"259","author":"Chebaiki","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib22","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1021\/jm060715y","article-title":"Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis","volume":"49","author":"He","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib23","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1007\/s00044-012-0340-3","article-title":"Oxadiazolo pyrrolidine carboxamides as enoyl-ACP reductase inhibitors: design, synthesis and antitubercular activity screening","volume":"22","author":"Sonia","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.116806_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114404","article-title":"Tapping into the antitubercular potential of 2, 5-dimethylpyrroles: a structure-activity relationship interrogation","volume":"237","author":"Semenya","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib25","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1021\/jm701560p","article-title":"1, 5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings","volume":"51","author":"Biava","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib26","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s00044-019-02418-1","article-title":"Chemical synthesis, molecular modeling and pharmacophore mapping of new pyrrole derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth","volume":"28","author":"Joshi","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.116806_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejmech.2015.10.008","article-title":"Structure activity relationships of 4-hydroxy-2-pyridones: a novel class of antituberculosis agents","volume":"106","author":"Ng","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010597","article-title":"Direct inhibitors of InhA are active against Mycobacterium tuberculosis","volume":"7","author":"Manjunatha","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2024.116806_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114502","article-title":"Recent contribution of medicinally active 2-aminothiophenes: a privileged scaffold for drug discovery","volume":"238","author":"Duvauchelle","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib30","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1021\/acs.jmedchem.8b00172","article-title":"Identification of morpholino thiophenes as novel Mycobacterium tuberculosis inhibitors, targeting QcrB","volume":"61","author":"Cleghorn","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib31","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1021\/acs.jmedchem.1c00263","article-title":"Discovery of novel thiophene-arylamide derivatives as DprE1 inhibitors with potent antimycobacterial activities","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112772","article-title":"Synthesis and evaluation of thiophene based small molecules as potent inhibitors of Mycobacterium tuberculosis","volume":"208","author":"Meena","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/jm0503493","article-title":"Synthesis of thieno[2, 3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H] glycine binding to the N-methyl-D-aspartate (NMDA) receptor","volume":"49","author":"Buchstaller","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib34","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1021\/ja504361y","article-title":"Cu-catalyzed cascades to carbocycles: union of diaryliodonium salts with alkenes or alkynes exploiting remote carbocations","volume":"136","author":"Zhang","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116806_bib35","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1016\/j.bmc.2009.06.014","article-title":"Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors","volume":"17","author":"Fuchigami","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib36","article-title":"Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116806_bib37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1039\/C8MD00212F","article-title":"Design, synthesis, and biological evaluation of m-amidophenol derivatives as a new class of antitubercular agents","volume":"9","author":"Zhang","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2024.116806_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41467-019-08464-y","article-title":"The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116806_bib39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jac\/dkr472","article-title":"Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence","volume":"67","author":"Andreu","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2024.116806_bib40","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1021\/acs.jmedchem.2c01647","article-title":"Structure\u2013activity relationship of novel pyrimidine derivatives with potent inhibitory activities against Mycobacterium tuberculosis","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115637","article-title":"3-Methoxy-2-phenylimidazo[1, 2-b]pyridazines highly active against Mycobacterium tuberculosis and Mycobacterium marinum","volume":"259","author":"Farrell","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116806_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800277","article-title":"Design, synthesis, and antitubercular activity of 3-amidophenols with 5-heteroatomic substitutions","volume":"352","author":"Zhang","year":"2019","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.116806_bib43","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1038\/s41467-022-33736-5","article-title":"Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs","volume":"13","author":"Green","year":"2022","journal-title":"Nat. Commun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T20:38:47Z","timestamp":1731271127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424006871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"alternative-id":["S0223523424006871"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116806","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of Thieno[3, 2-b]pyridinone derivatives exhibiting potent activities against Mycobacterium tuberculosis in vivo by targeting Enoyl-ACP reductase","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116806"}}